Febuxostat CAS 144060-53-7 Purity > 99.0% (HPLC) API Factory
Solarachadh ceimigeach Ruifu Febuxostat eadar-mheadhanach co-cheangailte:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS 25984-63-8
Ethyl 2- (3-Cyano-4-Hydroxyphenyl)-4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2- (3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2- (3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-01-2
Ethyl 2- (3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161798-03-4
Ethyl 2- (4-Hydroxyphenyl)-4-Methylthiazole-5-Carboxylate CAS 161797-99-5
Ainm Ceimigeach | Febuxostat |
Co-fhaclan | 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylic Acid |
Àireamh CAS | 144060-53-7 |
Inbhe Stoc | Ann an stoc, ìre toraidh suas gu tonna |
Foirmle Molecular | C16H16N2O3S |
Cuideam Molecular | 316.38 |
Rubha leaghaidh | 207.0 gu 211.0 ℃ |
Dùmhlachd | 1.31 ± 0.1 g / cm3 |
Brand | Ceimigeach Ruifu |
Nì | Sònrachaidhean |
Coltas | Pùdar criostalach geal gu neo-gheal |
Aithneachadh | HPLC/IR |
Purity / Modh Mion-sgrùdadh | > 99.0% (HPLC air stèidh tioram) |
Call air tiormachadh | <1.00% (Tioramaich e aig 105 ℃ ann an tiormaiche sèididh èadhair dealain gus am bi cuideam seasmhach) |
Fuigheall air Ignition | <0.10% |
Stuthan Co-cheangailte | |
Impurity singilte as àirde | <0.30% |
Impurities iomlan | <1.00% |
Chlorides | <0.04% |
Meatailtean Trom | <20ppm |
Inbhe deuchainn | Inbhe Iomairt |
Cleachdadh | API |
Pacaid: Botal, poca foil alùmanum, 25kg / druma cairt-bhòrd, no a rèir riatanas luchd-ceannach
Suidheachadh stòraidh:Bùth ann an soithichean dùinte ann an àite fionnar is tioram;Dìon bho sholas is taiseachd
Tha Febuxostat (CAS: 144060-53-7), air a reic fo na h-ainmean branda Uloric agus Adenuric am measg feadhainn eile, na chungaidh-leigheis a thathas a’ cleachdadh san fhad-ùine airson gout a làimhseachadh mar thoradh air ìrean searbhag uric àrd.Mar as trice thathar a 'moladh a-mhàin do dhaoine nach urrainn allopurinol a ghabhail.Nuair a thòisichear an toiseach, thathas gu tric a’ moladh cungaidhean-leigheis leithid NSAIDs gus casg a chuir air lasraichean gout.Tha e air a ghlacadh le beul.Chaidh Febuxostat aontachadh airson cleachdadh meidigeach san Aonadh Eòrpach ann an 2008 agus anns na Stàitean Aonaichte ann an 2009. Tha Febuxostat air a chleachdadh airson gout leantainneach agus hyperuricemia a làimhseachadh.Mar as trice chan eil Febuxostat air a mholadh ach airson daoine nach urrainn gabhail ri allopurinol.